Education
About Us
Working with TipRanks
Follow Us
Cory Kasimov Profile - Evercore ISI Analyst
851 Followers
Cory Kasimov Evercore ISI
Wall Street Analyst
Success Rate
273 out of 491 ratings made a profit
Average Return
+16.50%
Average return per rating
Time Frame
Compare to
Copying Cory Kasimov's trades since 2010 and holding each position for 1 Year would result in 55.60% of your transactions generating a profit, with an average return of 16.5% per rating.
Stock Rating Distribution
63.78% Buy
32.59% Hold
3.63% Sell
Distribution of Cory Kasimov's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Cory Kasimov
Cory Kasimov's Stock Coverage
Amylin Pharmaceuticals
Jun 18, 2010
Buy
Upgraded
―
1Ratings
―
0.00%
Arena Pharma
Jul 16, 2010
Buy
Upgraded
―
1Ratings
―
0.00%
ImmunoGen
Aug 27, 2012
Hold
Reiterated
―
2Ratings
―
0.00%
Onyx Pharma
Mar 28, 2013
Buy
Reiterated
―
1Ratings
―
0.00%
Rigel
Jun 04, 2013
Hold
Downgraded
―
1Ratings
―
0.00%
Orexigen
Nov 27, 2013
Buy
Reiterated
―
4Ratings
―
0.00%
Vivus
May 06, 2014
Hold
Assigned
―
5Ratings
―
0.00%
Infinity Pharmaceuticals
May 07, 2014
Buy
Assigned
$20.00
―
2Ratings
―
0.00%
BioCryst
Dec 09, 2014
Buy
Assigned
$18.00
(150.70% Upside)
2Ratings
―
0.00%
JPMorgan Chase
Jan 13, 2015
Hold
Reiterated
―
1Ratings
―
0.00%
List of latest recommendations made by Cory Kasimov. Click to expand and see Cory Kasimov's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Cory Kasimov activity FAQ
What is the performance of Cory Kasimov's recommendations?
The percentage of profitable recommendations made by Cory Kasimov is 56%, and the average return per transaction is 16.50%.
What was Cory Kasimov's most profitable rating?
Cory Kasimov’s most profitable ratings was a buy on MRNA stock on Aug 07, 2019 - Jul 20, 2020. The return on the trade was +543.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here